Olazax (Olanzapine): Uses, Dosage & Side Effects

Atypical antipsychotic tablet for schizophrenia and bipolar disorder

Prescription Required ATC: N05AH03 Atypical Antipsychotic
Active Ingredient
Olanzapine
Available Form
Tablet
Strength
5 mg
Brand Name
Olazax
Medically reviewed | Last reviewed: | Evidence level: 1A
Olazax is a brand of olanzapine, an atypical (second-generation) antipsychotic medicine used to treat schizophrenia and moderate-to-severe manic episodes in bipolar disorder. Supplied as 5 mg oral tablets, Olazax works by modulating dopamine and serotonin activity in the brain, helping to reduce hallucinations, delusions, disorganised thinking, and severe mood episodes. Olazax is taken once daily and is available only on prescription. Regular monitoring of weight, blood sugar, and cholesterol is essential during treatment.
📅 Published:
📅 Reviewed:
Reading time: 16 minutes
Written and reviewed by iMedic Medical Editorial Team | Specialists in clinical pharmacology and psychiatry

Quick Facts About Olazax

Active Ingredient
Olanzapine
Thienobenzodiazepine
Drug Class
Antipsychotic
Atypical / Second-generation
ATC Code
N05AH03
WHO classification
Common Uses
Schizophrenia
Bipolar disorder (mania)
Available Form
5 mg tablet
Oral administration
Prescription Status
Rx Only
Prescription required

Key Takeaways About Olazax

  • Primary indications: Olazax treats schizophrenia and moderate-to-severe manic episodes in bipolar disorder, and prevents recurrence of mania
  • Metabolic monitoring is essential: Weight gain, elevated blood sugar, and raised cholesterol are common with olanzapine — regular blood tests and weight checks are critical
  • Do not stop suddenly: Abrupt discontinuation may cause withdrawal symptoms including insomnia, sweating, tremor, and nausea
  • Not for elderly with dementia: Olazax is not recommended in elderly patients with dementia due to increased risk of stroke and death
  • Takes 2–4 weeks for full effect: Sedation occurs quickly, but the full antipsychotic effect develops over several weeks

What Is Olazax and What Is It Used For?

Olazax is a brand of olanzapine, an atypical (second-generation) antipsychotic that modulates dopamine and serotonin signalling in the brain. It is primarily prescribed for schizophrenia and moderate-to-severe manic episodes in bipolar disorder, and helps prevent recurrence of mania in patients who respond to initial treatment.

Olazax contains the active substance olanzapine, which belongs to the thienobenzodiazepine class of atypical antipsychotics. Olanzapine is one of the most widely prescribed medications for serious mental health conditions worldwide and is listed on the WHO Model List of Essential Medicines, reflecting its importance in global healthcare. Unlike older (first-generation) antipsychotics that primarily block dopamine receptors, the olanzapine in Olazax acts on multiple neurotransmitter systems simultaneously.

Olazax works by blocking several types of receptors in the brain, including dopamine D1–D4 receptors, serotonin 5-HT2A and 5-HT2C receptors, muscarinic M1–M5 receptors, histamine H1 receptors, and alpha-1 adrenergic receptors. This broad receptor profile contributes to its effectiveness against both the positive symptoms of psychosis (hallucinations, delusions, disorganised speech) and the negative symptoms (social withdrawal, flat affect, reduced motivation). The balanced effect on serotonin and dopamine also reduces the risk of extrapyramidal motor side effects compared with first-generation antipsychotics.

Olazax is supplied as a 5 mg tablet for oral administration. The 5 mg strength is frequently used as a starting dose, as a maintenance dose in combination with other strengths, or as a single dose in patients with increased sensitivity to the medication, such as elderly patients or those with hepatic impairment. The dose is titrated individually by the prescribing doctor based on clinical response and tolerability.

Schizophrenia

Schizophrenia is a chronic psychiatric condition characterised by symptoms such as hearing, seeing, or sensing things that are not there (hallucinations), holding fixed false beliefs (delusions), unusual suspiciousness, disorganised thinking, and social withdrawal. People with schizophrenia may also experience depression, anxiety, and tension. Olazax helps manage these symptoms by restoring the balance of neurotransmitter activity in the brain.

Clinical evidence from large-scale meta-analyses, including a landmark 2019 Lancet study comparing 32 antipsychotics, demonstrates that olanzapine (the active ingredient in Olazax) is among the most effective medications for treating acute schizophrenia episodes. International treatment guidelines from NICE (UK), APA (US), and the World Federation of Societies of Biological Psychiatry (WFSBP) consistently include olanzapine as a first-line option for acute and maintenance treatment of schizophrenia.

Bipolar disorder — manic episodes

Bipolar disorder involves extreme mood swings between manic episodes (periods of elevated mood, excessive energy, reduced need for sleep, and impulsive behaviour) and depressive episodes. Olazax is used to treat moderate to severe manic episodes. It can rapidly reduce agitation, racing thoughts, and grandiosity associated with mania, often within a few days of starting treatment.

Furthermore, Olazax is effective as maintenance therapy to prevent recurrence of manic episodes in patients who responded well to the medication during the acute phase. Long-term maintenance typically requires ongoing treatment for at least 12–24 months after an initial manic episode, with duration individualised based on the patient's history and risk of relapse.

Important to know:

Olazax should always be used under the supervision of a psychiatrist or other specialist experienced in treating serious mental health conditions. The decision to start, adjust, or stop Olazax should be made jointly between patient and clinician, considering the balance of benefits and risks for each individual.

What Should You Know Before Taking Olazax?

Before starting Olazax, inform your doctor about all existing medical conditions, current medications, and whether you are pregnant or breastfeeding. Olazax has important contraindications, warnings, and interactions that must be considered to ensure safe and effective treatment.

Olazax is a potent medication that affects several organ systems beyond the brain. Before starting treatment, your doctor will need a comprehensive picture of your health to minimise risks. This includes baseline measurements of your weight, blood glucose, lipid profile (cholesterol and triglycerides), and blood pressure. These values will be monitored at regular intervals throughout treatment, typically at 3 months and then annually, or more frequently if abnormalities develop.

An electrocardiogram (ECG) may also be performed before starting Olazax in patients with cardiovascular risk factors, as olanzapine can rarely cause changes in heart rhythm. A complete blood count may be checked periodically, since olanzapine can infrequently affect white blood cell production.

Contraindications

You should not take Olazax if you have a known allergy (hypersensitivity) to olanzapine or any of the other ingredients in the tablet. An allergic reaction may present as skin rash, itching, swelling of the face or lips, or difficulty breathing. If any of these symptoms occur, stop the medication and contact your doctor immediately.

Olazax is also contraindicated in patients with known risk of narrow-angle glaucoma (increased pressure in the eye). The anticholinergic properties of olanzapine can precipitate an acute angle-closure attack in susceptible individuals. If you have been diagnosed with or are at risk for this condition, discuss alternative medications with your doctor.

Warnings and precautions

There are several important medical conditions and risk factors that your doctor needs to be aware of before prescribing Olazax:

Elderly patients with dementia:

Olazax is not recommended for use in elderly patients with dementia-related psychosis. Studies have shown an increased risk of stroke, pneumonia, urinary incontinence, falls, elevated body temperature, skin redness, gait difficulties, extreme fatigue, and death in this population. If you are caring for an elderly person with dementia, discuss safer alternatives with their doctor.

Tell your doctor if you have or have ever had any of the following conditions:

  • Stroke or transient ischaemic attack (TIA) — Olazax may increase cerebrovascular risk
  • Parkinson's disease — olanzapine may worsen Parkinsonian symptoms
  • Diabetes mellitus — Olazax can significantly raise blood glucose levels
  • Heart disease — including arrhythmias, heart failure, or recent myocardial infarction
  • Liver or kidney disease — dose adjustments may be necessary
  • Epilepsy or seizure history — Olazax can lower the seizure threshold
  • Prostate problems — urinary retention may occur
  • Bowel obstruction (paralytic ileus)
  • Blood disorders — olanzapine may affect white blood cell counts
  • History of blood clots (venous thromboembolism) — antipsychotics have been associated with increased clotting risk

Patients over 65 years of age should have their blood pressure monitored regularly during treatment, as Olazax can cause orthostatic hypotension (a drop in blood pressure when standing up), which increases the risk of falls and injury.

Metabolic syndrome risk:

Olazax carries a significant risk of causing metabolic syndrome, including weight gain, high blood sugar (hyperglycaemia), and elevated blood fats (dyslipidaemia). Your doctor should test your blood glucose and lipid levels before starting Olazax and at regular intervals during treatment. Referral to a dietitian or provision of dietary advice may be recommended. Regular physical activity is encouraged throughout treatment.

Children and adolescents

Olazax is not intended for use in patients under 18 years of age. Clinical data on the safety and efficacy of olanzapine in children and adolescents is limited, and the metabolic side effects (weight gain, glucose and lipid changes) may be more pronounced in younger patients. If an antipsychotic is needed for a child or adolescent, the prescribing doctor will consider age-appropriate alternatives.

Pregnancy and breastfeeding

If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor before taking Olazax. The medication should only be used during pregnancy if the potential benefits clearly outweigh the risks to the foetus. Olanzapine is not a known teratogen, but limited data are available from controlled studies in pregnant women.

Newborns whose mothers took Olazax during the third trimester may experience withdrawal or extrapyramidal symptoms including tremor, muscle stiffness or weakness, sleepiness, agitation, breathing difficulties, and feeding problems. If your baby develops any of these symptoms after birth, contact your doctor promptly. Many of these symptoms are transient and resolve within days to weeks.

Small amounts of olanzapine pass into breast milk. Breastfeeding is not recommended during Olazax treatment. Discuss alternative feeding methods with your doctor if you need to continue the medication while caring for a newborn.

Driving and operating machinery

Olazax can cause drowsiness, dizziness, and blurred vision, particularly during the initial phase of treatment or after dose increases. Do not drive or operate heavy machinery until you know how Olazax affects you. If drowsiness persists, discuss this with your doctor, as dose adjustment or timing changes (for example, taking Olazax in the evening) may help.

How Does Olazax Interact with Other Drugs?

Olazax interacts with several medications that can increase or decrease its effects. Key interactions include carbamazepine (which decreases olanzapine levels), fluvoxamine and ciprofloxacin (which increase olanzapine levels), and central nervous system depressants including alcohol. Always inform your doctor of all medications you take.

Drug interactions with Olazax can occur through several mechanisms, including effects on liver enzymes (particularly CYP1A2 and CYP2D6) that metabolise olanzapine, and additive pharmacological effects on the central nervous system. It is crucial that your doctor and pharmacist are aware of all medications you are taking, including prescription drugs, over-the-counter medicines, and herbal supplements such as St John's Wort.

Major interactions

The following interactions are clinically significant and may require dose adjustments or close monitoring:

Clinically significant drug interactions with Olazax (olanzapine)
Drug Effect Mechanism Action Required
Carbamazepine Decreases olanzapine levels by up to 50% CYP1A2 induction Olazax dose increase may be needed
Fluvoxamine Increases olanzapine levels significantly Strong CYP1A2 inhibition Olazax dose reduction required
Ciprofloxacin Increases olanzapine levels CYP1A2 inhibition Monitor closely; dose adjustment may be needed
Levodopa / Dopamine agonists Mutual antagonism Opposing effects on dopamine receptors May worsen Parkinson's symptoms; avoid if possible
Benzodiazepines (e.g., diazepam) Additive sedation, respiratory depression risk CNS depression Use with caution; monitor for excessive sedation
Lithium / Valproate Increased risk of tremor, sedation, neurotoxicity Additive CNS effects Monitor closely when combined in bipolar disorder

Minor interactions and other notable considerations

Alcohol: Do not consume alcohol while taking Olazax. The combination can cause excessive drowsiness, impaired judgement, and respiratory depression. Alcohol can worsen many of the side effects of Olazax, including postural hypotension.

Antidepressants and anxiolytics: Taking Olazax together with certain antidepressants or anti-anxiety medications may increase sedation. Your doctor may adjust the doses of either medication to minimise this effect. There is some evidence that combining SSRIs with olanzapine can be beneficial in treatment-resistant depression.

Antihypertensives: Olazax can lower blood pressure. When combined with blood pressure medications, excessive hypotension may occur. Blood pressure monitoring is recommended, especially during the first weeks of combined treatment and after any dose change.

Smoking: Tobacco smoking induces CYP1A2, which metabolises olanzapine. Patients who smoke may require higher doses of Olazax. Conversely, if you stop smoking during treatment, olanzapine levels may rise and your doctor may need to reduce the dose. Nicotine replacement therapy does not have this inducing effect, so dose adjustments may become relevant when transitioning from smoking to nicotine patches or gum.

QT-prolonging drugs: Combining Olazax with other medicines that prolong the QT interval (such as some antiarrhythmics, antibiotics, or antifungals) should be done with caution, as rare cases of QT prolongation have been reported with olanzapine.

What Is the Correct Dosage of Olazax?

The typical adult dose of Olazax ranges from 5 mg to 20 mg taken once daily. Olazax 5 mg tablets are commonly used as a starting dose, in titration, or as maintenance in patients with higher sensitivity. The starting dose depends on the condition being treated and is adjusted based on clinical response and tolerability. Always take Olazax exactly as prescribed by your doctor.

The dose of Olazax is individualised by your prescribing doctor based on your specific condition, symptom severity, age, other medications, and overall health. Olazax should be taken once daily, at approximately the same time each day, with or without food. Treatment duration is determined by your doctor and may be long-term for chronic conditions such as schizophrenia.

Adults

Recommended Olazax (olanzapine) doses for adults
Indication Starting Dose Usual Range Maximum Dose
Schizophrenia 10 mg/day 5–20 mg/day 20 mg/day
Acute mania (bipolar, monotherapy) 15 mg/day 5–20 mg/day 20 mg/day
Acute mania (bipolar, combination) 10 mg/day 5–20 mg/day 20 mg/day
Bipolar maintenance 10 mg/day 5–20 mg/day 20 mg/day

Dose adjustments should be made at intervals of no less than 24 hours, typically in increments of 5 mg. Olazax 5 mg tablets are particularly useful for fine titration of the dose. Your doctor will aim to find the lowest effective dose that controls your symptoms while minimising side effects.

Elderly patients

A lower starting dose of 5 mg/day (one Olazax tablet) may be considered for elderly patients, particularly those over 65 years. Dose increases should be made more cautiously, with careful monitoring for orthostatic hypotension, sedation, and falls. As noted above, Olazax is not recommended for elderly patients with dementia-related psychosis.

Patients with liver or kidney impairment

A lower starting dose of 5 mg/day should be considered for patients with moderate hepatic (liver) impairment. Dose escalation should be cautious and guided by clinical response and tolerability. Olazax has not been adequately studied in patients with severe hepatic impairment, and alternative medications may be preferred. Renal (kidney) impairment does not generally require dose adjustment, but lower starting doses and careful titration are prudent.

How to take Olazax

Follow these guidelines when taking Olazax tablets:

  1. Swallow the tablet whole with a glass of water
  2. Take Olazax at the same time each day to maintain stable drug levels
  3. You may take Olazax with or without food — food does not affect absorption
  4. Do not crush or split the tablet unless specifically advised by your pharmacist
  5. Continue taking Olazax for the full duration prescribed, even if you feel better

Missed dose

If you forget to take your Olazax, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a forgotten one. Missing occasional doses is unlikely to cause significant problems, but regular missed doses can lead to symptom recurrence and should be discussed with your doctor.

Overdose

Signs of overdose — seek emergency help immediately:

Symptoms of Olazax overdose may include rapid heart rate, agitation or aggression, speech difficulties, involuntary movements (especially of the face or tongue), reduced consciousness, confusion, seizures, coma, fever, rapid or slow breathing, respiratory depression, abnormally high or low blood pressure, and abnormal heart rhythm. If you suspect an overdose, call your local emergency number immediately and bring any remaining Olazax tablets with you to the hospital. There is no specific antidote; treatment is supportive.

What Are the Side Effects of Olazax?

Like all medications, Olazax can cause side effects, though not everyone experiences them. The most common side effects include weight gain, drowsiness, and increased prolactin levels. Serious but rare effects include neuroleptic malignant syndrome (NMS), tardive dyskinesia, and venous thromboembolism. Report any concerning symptoms to your doctor.

Side effects of Olazax can range from mild and temporary to serious and potentially life-threatening. The metabolic effects (weight gain, blood sugar changes, lipid changes) are among the most clinically significant and require ongoing monitoring. Many of the common side effects, such as drowsiness and dizziness, tend to be most pronounced at the start of treatment and often improve over the first few weeks.

Seek immediate medical attention if you experience:

Neuroleptic malignant syndrome (NMS): A rare but potentially fatal combination of high fever, rapid breathing, sweating, muscle rigidity, and drowsiness or confusion. Tardive dyskinesia: Involuntary, repetitive movements especially of the face or tongue. Blood clots: Swelling, pain, or redness in the leg, chest pain, or sudden difficulty breathing. Severe allergic reaction: Swelling of the face, lips, or throat, or difficulty breathing.

Very Common

Affects more than 1 in 10 people
  • Weight gain (often significant)
  • Drowsiness and somnolence
  • Elevated prolactin levels
  • Orthostatic dizziness (especially when standing up, at start of treatment)

Common

Affects 1 in 10 to 1 in 100 people
  • Increased appetite
  • Elevated blood glucose and cholesterol levels
  • Elevated triglycerides
  • Temporarily elevated liver enzymes
  • Increased uric acid and creatine phosphokinase
  • Dizziness, restlessness (akathisia)
  • Tremor and movement difficulties (dyskinesia)
  • Constipation, dry mouth
  • Skin rash
  • Weakness, extreme fatigue
  • Fluid retention (swelling in hands, ankles, or feet)
  • Fever, joint pain
  • Sexual dysfunction (decreased libido, erectile dysfunction)

Uncommon

Affects 1 in 100 to 1 in 1,000 people
  • Hypersensitivity reactions (swelling of mouth/throat, itching, rash)
  • Diabetes or worsening of existing diabetes, potentially with ketoacidosis
  • Seizures (especially in those with a history of epilepsy)
  • Muscle rigidity or spasms (including eye movements)
  • Restless legs syndrome
  • Speech difficulties, stuttering
  • Slow heartbeat (bradycardia)
  • Photosensitivity (increased sensitivity to sunlight)
  • Nosebleeds, abdominal bloating, drooling
  • Memory loss or forgetfulness
  • Urinary incontinence, difficulty urinating
  • Hair loss
  • Absent or shortened menstrual periods
  • Breast changes (abnormal breast milk production, breast enlargement)

Rare

Affects 1 in 1,000 to 1 in 10,000 people
  • Lowered body temperature (hypothermia)
  • Abnormal heart rhythm (including QT prolongation)
  • Pancreatitis (severe abdominal pain, fever, nausea)
  • Liver disease (jaundice — yellowing of skin and eyes)
  • Rhabdomyolysis (muscle disease with unexplained pain)
  • Prolonged and/or painful erection (priapism)
  • Venous thromboembolism (blood clots in the legs or lungs)

Very Rare

Affects fewer than 1 in 10,000 people
  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) — a serious allergic reaction with flu-like symptoms, rash, fever, swollen lymph nodes, and elevated liver enzymes
  • Neuroleptic malignant syndrome (NMS)

Patients with Parkinson's disease

Olazax may worsen the motor symptoms of Parkinson's disease. If you have Parkinson's disease and are prescribed Olazax, your doctor will monitor you closely for any deterioration of your Parkinsonian symptoms. In many cases, alternative antipsychotics with a lower risk of extrapyramidal effects (such as quetiapine or clozapine) will be preferred.

Reporting side effects:

It is important to report any suspected side effects to your healthcare provider. You can also report side effects directly to your national pharmacovigilance authority (e.g., the FDA MedWatch programme in the US, the Yellow Card Scheme in the UK, or the EMA's EudraVigilance system in the EU). Reporting helps ensure ongoing monitoring of the benefit-risk balance of medications.

What Happens If You Stop Taking Olazax?

Do not stop Olazax abruptly. Sudden discontinuation can cause withdrawal symptoms including sweating, insomnia, tremor, anxiety, nausea, and vomiting. Your doctor will recommend a gradual dose reduction when it is appropriate to stop treatment.

It is essential that you continue taking Olazax as prescribed by your doctor, even if you feel better. Many psychiatric conditions are chronic in nature, and stopping medication prematurely significantly increases the risk of relapse. Studies show that patients with schizophrenia who discontinue antipsychotic treatment have relapse rates of 60–80% within a year, compared to 20–30% for those who continue maintenance therapy.

If you and your doctor decide to discontinue Olazax, the dose should be reduced gradually over several weeks rather than stopped suddenly. Abrupt cessation may cause discontinuation symptoms including:

  • Excessive sweating
  • Difficulty sleeping (insomnia)
  • Tremor and shaking
  • Anxiety and irritability
  • Nausea and vomiting
  • Rebound psychotic symptoms

Your doctor will create a tapering schedule tailored to your situation, typically reducing the dose by small increments (for example, by 5 mg using Olazax 5 mg tablets) every 1–2 weeks while monitoring for any return of symptoms or withdrawal effects.

How Should You Store Olazax?

Store Olazax in its original packaging, away from light and moisture, at room temperature. Keep out of reach of children. Do not use after the expiry date printed on the packaging.

Proper storage of Olazax helps ensure the medication remains effective and safe throughout its shelf life. Follow these storage guidelines:

  • Keep in original packaging — the blister pack or bottle protects the tablets from light and moisture
  • Store at room temperature — typically below 25°C; avoid extreme heat or cold
  • Protect from light — do not remove tablets from the blister pack until ready to take
  • Protect from moisture — do not store in bathrooms or kitchens where humidity is high
  • Keep out of sight and reach of children
  • Check the expiry date — do not use Olazax after the date shown on the packaging; the expiry date refers to the last day of that month

Do not dispose of Olazax via household waste or down the drain. Return unused or expired Olazax to your pharmacist for safe disposal. This helps protect the environment and prevent accidental exposure.

What Does Olazax Contain?

The active ingredient in Olazax is olanzapine 5 mg. The inactive ingredients (excipients) include pharmaceutical grade fillers, binders, disintegrants, and lubricants that help form a stable, bioavailable tablet.

Each Olazax tablet contains 5 mg of olanzapine as the active ingredient. The inactive ingredients (excipients) serve various pharmaceutical purposes such as binding, filling, enabling dissolution, and providing a stable tablet that can be reliably manufactured.

Typical excipients in Olazax tablets

  • Microcrystalline cellulose — binder and filler that provides bulk to the tablet
  • Lactose monohydrate — filler and diluent (may be present in some formulations)
  • Crospovidone — disintegrant that helps the tablet break apart in the stomach
  • Hydroxypropyl cellulose — binder
  • Magnesium stearate — lubricant used during manufacturing
  • Colloidal anhydrous silica — flow agent
Lactose warning:

If the specific Olazax formulation you receive contains lactose, patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should consult their doctor before taking this medicine. Check the package leaflet of the product you have been prescribed or ask your pharmacist if you have any concerns.

Olanzapine, the active ingredient in Olazax, is also available under numerous other brand names worldwide, including Zyprexa (the original brand from Eli Lilly), Zalasta, Olanzapine Accord, Olanzapine Viatris, Olanzapine Glenmark, and many generics. All approved versions must demonstrate bioequivalence, meaning they deliver the same amount of active drug into the bloodstream at the same rate as the reference product.

Product description

Olazax 5 mg tablets are typically round, film-coated tablets. The exact appearance (colour, marking, scoring) depends on the specific manufacturer. Always check that the tablets you receive match the description in the package leaflet and inform your pharmacist if they appear different from those you have been taking previously.

Frequently Asked Questions About Olazax

Olazax contains olanzapine, an atypical antipsychotic medication used to treat schizophrenia and moderate-to-severe manic episodes in bipolar disorder. It helps manage symptoms such as hallucinations, delusions, disorganised thinking, and severe mood swings. Olazax is also used as maintenance therapy in bipolar disorder to prevent recurrence of manic episodes in patients who responded to initial treatment.

The most common side effects of Olazax (affecting more than 1 in 10 people) include weight gain, drowsiness/somnolence, elevated prolactin levels, and orthostatic hypotension (dizziness when standing up). Olanzapine is particularly associated with significant metabolic effects including raised blood sugar levels, increased cholesterol and triglycerides. Regular monitoring of weight, blood glucose, and lipid levels is essential during treatment with Olazax.

No, you should not stop taking Olazax suddenly without medical supervision. Abruptly discontinuing olanzapine can cause withdrawal symptoms including sweating, insomnia, tremor, anxiety, nausea, and vomiting. Your doctor will usually recommend gradually reducing the dose over time. Always consult your doctor before making any changes to your medication.

Yes, weight gain is one of the most common side effects of Olazax. Studies show that significant weight gain occurs in a majority of patients, with some gaining 7% or more of their initial body weight. This is more pronounced than with many other antipsychotics. Regular weight monitoring, dietary counselling, and physical activity are recommended throughout treatment. Your doctor may consider switching medications if weight gain becomes excessive.

Olazax should only be used during pregnancy if the potential benefit justifies the potential risk to the foetus. Newborns exposed to antipsychotics during the third trimester may experience withdrawal symptoms including tremor, muscle stiffness, weakness, sleepiness, agitation, breathing problems, and feeding difficulties. Women who are pregnant or planning to become pregnant should discuss the risks and benefits with their doctor. Olanzapine passes into breast milk, so breastfeeding is not recommended during treatment.

Some effects of Olazax, particularly sedation and calming effects, may be noticed within hours to days. However, the full antipsychotic effect typically takes 2 to 4 weeks to develop, and for some patients it may take 6 to 8 weeks. It is important to continue taking the medication as prescribed even if you do not notice immediate improvement. Do not stop taking Olazax without consulting your doctor.

Olazax and Zyprexa both contain the same active ingredient, olanzapine. Zyprexa is the original brand developed by Eli Lilly, while Olazax is a generic version containing identical active drug. Approved generic versions must demonstrate bioequivalence to the original product, meaning they deliver the same amount of active drug into the bloodstream at the same rate. The therapeutic effects and safety profiles are considered equivalent, so switching between Olazax and Zyprexa typically does not require dose adjustment.

References

  1. World Health Organization. WHO Model List of Essential Medicines — 23rd List (2023). Geneva: WHO; 2023. Available from: who.int
  2. European Medicines Agency. Zyprexa (olanzapine) — Summary of Product Characteristics. EMA; 2024. Available from: ema.europa.eu
  3. U.S. Food and Drug Administration. Zyprexa (olanzapine) Prescribing Information. FDA; 2024.
  4. Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939–951. doi:10.1016/S0140-6736(19)31135-3
  5. National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: prevention and management (CG178). NICE; 2024.
  6. British National Formulary. Olanzapine. BNF; 2024. Available from: bnf.nice.org.uk
  7. Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951–962.
  8. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Schizophrenia. 3rd ed. APA; 2021.
  9. Correll CU, Solmi M, Croatto G, et al. Mortality in people with schizophrenia: a systematic review and meta-analysis of studies. World Psychiatry. 2022;21(2):304–317.
  10. Taylor DM, Barnes TRE, Young AH. The Maudsley Prescribing Guidelines in Psychiatry. 14th ed. Wiley-Blackwell; 2021.
  11. Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14(3):154–219.

Editorial Team

This article was written and reviewed by the iMedic Medical Editorial Team, comprising licensed specialist physicians in clinical pharmacology and psychiatry. Our editorial process follows the GRADE evidence framework and adheres to international medical guidelines from the WHO, EMA, FDA, NICE, and APA.

Medical Writing

Content developed by medical professionals with expertise in pharmacology and psychiatric medicine, following evidence-based medicine principles.

Medical Review

Independently reviewed by the iMedic Medical Review Board to ensure accuracy, completeness, and adherence to current clinical guidelines.

Evidence Standards

All medical claims are supported by Level 1A evidence (systematic reviews and meta-analyses of randomised controlled trials) where available.

Independence

No commercial funding. No pharmaceutical company sponsorship. Independent medical editorial content with full editorial independence.